<bill session="108" type="s" number="1225" updated="2023-01-15T16:48:44Z">
  <state datetime="2003-06-11">REPORTED</state>
  <status>
    <unknown datetime="2003-06-11"/>
  </status>
  <introduced datetime="2003-06-10"/>
  <titles>
    <title type="display">Greater Access to Affordable Pharmaceuticals Act</title>
    <title type="official" as="introduced">A bill entitled the "Greater Access to Affordable Pharmaceuticals Act".</title>
    <title type="short" as="introduced">Greater Access to Affordable Pharmaceuticals Act</title>
  </titles>
  <sponsor bioguide_id="G000445"/>
  <cosponsors>
    <cosponsor bioguide_id="K000105" joined="2003-06-10"/>
    <cosponsor bioguide_id="M000303" joined="2003-06-10"/>
    <cosponsor bioguide_id="M001141" joined="2003-06-23"/>
    <cosponsor bioguide_id="S000148" joined="2003-06-10"/>
  </cosponsors>
  <actions>
    <action datetime="2003-06-10">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-06-10" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2003-06-11" state="REPORTED">
      <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill session="108" type="h" number="2491" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Antitrust law"/>
    <term name="Civil actions and liability"/>
    <term name="Commerce"/>
    <term name="Consent decrees"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Generic drugs"/>
    <term name="Government Operations and Politics"/>
    <term name="Intellectual property"/>
    <term name="Law"/>
    <term name="Marketing"/>
    <term name="Patent infringement"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Punitive damages"/>
    <term name="Restrictive trade practices"/>
    <term name="Science, Technology, Communications"/>
  </subjects>
  <amendments/>
  <summary date="2003-10-17T21:50:05Z" status="Introduced in Senate">Greater Access to Affordable Pharmaceuticals Act - Amends the Federal Food, Drug, and Cosmetic Act to: (1) limit a brand name drug manufacturer to one Food and Drug Administration (FDA) 30-month stay of competition in a patent infringement suit against a generic drug applicant; (2) permit a generic applicant being sued to file a counterclaim to correct or delete patent information; (3) limit damages that a brand name manufacturer may recover in an instance where such manufacturer failed to file certain patent information; (4) permit a generic drug applicant to seek declaratory judgment regarding patent infringement prior to marketing a drug; (5) forfeit the180-day market exclusivity period for a first generic drug applicant to a subsequent generic applicant if the first applicant engages in certain activities which impede such drug's timely marketing; and (6) permit alternative means to determine bioequivalence for drugs that are not absorbed into the bloodstream.</summary>
</bill>
